News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biocept, Inc. Sets Price Range on Proposed IPO; Anticipates $17.7 Million in Net Proceeds



11/7/2013 7:50:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biocept Sets Price Range on Proposed IPO; Anticipates $17.7M in Net Proceeds

Biocept today set the price range on its planned initial public offering, saying it expects to price its shares between $10 and $12. In its amended Form S-1 filed on Tuesday with the US Securities and Exchange Commission, the circulating tumor cell diagnostics firm said that it expects to offer about 1.8 million shares of its common stock, netting proceeds of approximately $17.1 million at the midpoint price of $11 per share. It would net $20.5 million if the underwriters exercise their overallotment option in full.

Help employers find you! Check out all the jobs and post your resume.

Read at Genome Web
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES